Observational studyInternational journal of molecular sciences2026
Finerenone as a Third-Line Therapy for Persistent Proteinuria in Diabetic Kidney Transplant Recipients.
Carmine Secondulfo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.